90 related articles for article (PubMed ID: 3259598)
1. Mapping of biologically relevant sites on human IL-1 beta using monoclonal antibodies.
Massone A; Baldari C; Censini S; Bartalini M; Nucci D; Boraschi D; Telford JL
J Immunol; 1988 Jun; 140(11):3812-6. PubMed ID: 3259598
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to human recombinant interleukin 1 (IL 1)beta: quantitation of IL 1 beta and inhibition of biological activity.
Kenney JS; Masada MP; Eugui EM; Delustro BM; Mulkins MA; Allison AC
J Immunol; 1987 Jun; 138(12):4236-42. PubMed ID: 2438338
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody to the IL-1 beta peptide 163-171 blocks adjuvanticity but not pyrogenicity of IL-1 beta in vivo.
Boraschi D; Volpini G; Villa L; Nencioni L; Scapigliati G; Nucci D; Antoni G; Matteucci G; Cioli F; Tagliabue A
J Immunol; 1989 Jul; 143(1):131-4. PubMed ID: 2786529
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibition of IL-1 beta activities and receptor binding by monoclonal antibodies mapping within a discrete region of the protein.
Boraschi D; Villa L; Ghiara P; Presentini R; Bossù P; Censini S; Nucci D; Massone A; Rossi R; Flad HD
Lymphokine Cytokine Res; 1991 Oct; 10(5):377-84. PubMed ID: 1722713
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to murine IL-1 alpha. Production, characterization, and inhibition of membrane-associated IL-1 activity.
Fuhlbrigge RC; Sheehan KC; Schreiber RD; Chaplin DD; Unanue ER
J Immunol; 1988 Oct; 141(8):2643-50. PubMed ID: 3262667
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of monoclonal antibodies to human IL-4: application in an IL-4 ELISA and differential inhibition of IL-4 bioactivity on B cells and T cells.
van der Pouw Kraan T; Rensink I; Aarden L
Eur Cytokine Netw; 1993; 4(5):343-9. PubMed ID: 8117935
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of two neutralizing monoclonal antibodies to human interleukin-1 alpha.
Stya M; Dower SK; Prickett KS; Gillis S; Conlon PJ
J Biol Response Mod; 1988 Apr; 7(2):162-72. PubMed ID: 3258906
[TBL] [Abstract][Full Text] [Related]
8. Antiidiotypic antibodies mimic molecular and functional properties of human IL-1 beta in vitro and in vivo.
Soprana E; Vigo E; Verani A; Blom J; Siccardi AG; Vercelli D; Viale G
Lymphokine Cytokine Res; 1994 Oct; 13(5):325-30. PubMed ID: 7858065
[TBL] [Abstract][Full Text] [Related]
9. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells.
Pober JS; Bevilacqua MP; Mendrick DL; Lapierre LA; Fiers W; Gimbrone MA
J Immunol; 1986 Mar; 136(5):1680-7. PubMed ID: 3485132
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1 beta activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein.
Yoon DY; Dinarello CA
J Immunol; 1998 Apr; 160(7):3170-9. PubMed ID: 9531272
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing monoclonal antibodies to human IL-8 receptor A map to the NH2-terminal region of the receptor.
Chuntharapai A; Lee J; Burnier J; Wood WI; Hébert C; Kim KJ
J Immunol; 1994 Feb; 152(4):1783-9. PubMed ID: 8120387
[TBL] [Abstract][Full Text] [Related]
12. Human interleukin 1: structure-function relationship.
Boraschi D; Tagliabue A
Ann Ist Super Sanita; 1990; 26(3-4):273-82. PubMed ID: 2091500
[TBL] [Abstract][Full Text] [Related]
13. Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains.
Boraschi D; Bossù P; Ruggiero P; Tagliabue A; Bertini R; Macchia G; Gasbarro C; Pellegrini L; Melillo G; Ulisse E; Visconti U; Bizzarri C; Del Grosso E; Mackay AR; Frascotti G; Frigerio F; Grifantini R; Grandi G
J Immunol; 1995 Nov; 155(10):4719-25. PubMed ID: 7594472
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody which has the neutralizing activities for human IL-2.
Sato H; Natsuume-Sakai S; Miyawaki T; Taga K; Hatano M; Taniguchi N
J Biol Response Mod; 1986 Apr; 5(2):191-201. PubMed ID: 3488373
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to human interleukin-1 beta and their use in a sensitive two-site enzyme linked immunosorbent assay.
Fontaine S; Damais C; Lando D; Cousin MA
Lymphokine Res; 1989; 8(2):129-39. PubMed ID: 2471900
[TBL] [Abstract][Full Text] [Related]
16. A rat monoclonal antibody that binds specifically to mouse T lymphoblasts and inhibits IL 2 receptor functions: a putative anti-IL 2 receptor antibody.
Osawa H; Diamantstein T
J Immunol; 1984 May; 132(5):2445-50. PubMed ID: 6425405
[TBL] [Abstract][Full Text] [Related]
17. Generation of monoclonal antibodies to murine IL-1 beta and demonstration of IL-1 in vivo.
Hogquist KA; Nett MA; Sheehan KC; Pendleton KD; Schreiber RD; Chaplin DD
J Immunol; 1991 Mar; 146(5):1534-40. PubMed ID: 1993843
[TBL] [Abstract][Full Text] [Related]
18. Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody.
Perretti M; Ahluwalia A; Harris JG; Goulding NJ; Flower RJ
J Immunol; 1993 Oct; 151(8):4306-14. PubMed ID: 8409403
[TBL] [Abstract][Full Text] [Related]
19. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
20. Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation.
Hernández-Caselles T; Stutman O
J Immunol; 1993 Oct; 151(8):3999-4012. PubMed ID: 8409382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
